Accordingly, the average weight of harvested PTX3-overexpressing MC17-51 and HT-1080 tumors was significantly reduced when compared to mock derived lesions (Figures 3A,B) and was also accompanied by a reduction in pHH3+ proliferating cells and of CD31+ tumor vessels (Figure 3B). The gene discussed is PTX3; the disease is neoplasm.